1Baeke F, Etten EV, Gysemans C, et al. Vitamin D signaling in immune - mediated disorders: Evolving insights and therapeutic opportunities [ J]. Mol Aspects Med, 2008, 29 : 376.
2Colston KW. Vitamin D and breast cancer risk [ J]. Best Pract Res Clin Endocrinol metab, 2008, 22 (4): 587.
3Hector FD, Margherita TC. Vitamin D: Its role and uses in immunology [J]. Faseb J, 2001, 15 (12): 2579.
4Christakos S, Dhawan P, Liu Y, et al. New insights into the mechanisms of vitamin D [ J ]. J cell Biochem, 2003, 88 (4) : 695.
5Scjwartz GG. Vitamin D and intervention trials in prostate cancer: From theory to therapy [ J ]. Ann Epidemiol, 2009, 19 (2): 96.
6Gorham ED, Garland FC, Garland CF. Starlight and breast cancer incidence in the USSR [J]. Int J Epidemiol, 1990, 19 : 820.
7Ebert R, Schutze N, Adamski J, et al. Vitamin D signaling is modulated on multiple levels in health and disease [ J ]. Mol Cell Endocrinol, 2006, 248 (1 -2): 149.
8Cantorna MT, Zhu Y, Froicu M, et al. Vitamin D status, 1, 25- dihydroxyvitamin D3, and the immune system [ J ]. Am J Clin Nutr, 2004, 80 (Suppl): 1717S.
9Kutuzova GD, Deluca HF. Gene expression profiles in rat intestine indentify phthways for 1, 25 -dihydroxyvitamin D3 stimulated calcium absorptrin and clarify its immunomodulatory properties [J]. Arch Biochem Biophy, 2004, 432, 152.
10Guy M, Lowe LC, Bretherton -Watt D, et al. Vitamin D receptor gene polymorphism and breast cancer risk [ J ]. Clin Cancer Res, 2004, 10 : 5472.
